Explosive Anktiva sales, new cancer data, and fresh approvals are rapidly redefining this immunotherapy story, today, Jan. 16 ...
Exxon Mobil stock remains a "Buy" with a plan for $25 billion in earnings and $35 billion in cash flow by 2030. Learn more ...
Billionaire Brad Jacobs' QXO said it has secured an additional $1.8 billion in ​financing, led by Apollo Global Management ...
MarketBeat on MSN
Eli Lilly stock rallies as Ventyx deal calms Wegovy concerns
In the last few months of 2025, shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) went on an undeniable hot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback